Article
Cornea tolerates prolonged exposure to viscoadaptive
Eugene, OR-Prolonged presence of 2.3% sodium hyaluronate (Healon5, Pfizer) in the eye in association with its use for anterior chamber stabilization following trabeculectomy appears to be well-tolerated by the cornea, according to results of a study undertaken by Richard S. Hoffman, MD, and colleagues at the Oregon Eye Institute, Eugene.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
